Katada Yoshiaki
Department of Radiology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.
Interv Radiol (Higashimatsuyama). 2020 Sep 30;5(3):114-119. doi: 10.22575/interventionalradiology.2020-0016. eCollection 2020 Oct 30.
EVAR has been used clinically for almost three decades, and it has been widely applied in clinical practice and has been applied to difficult cases as devices and techniques have evolved. Although the major advantage of EVAR is its lower perioperative mortality, compared with open surgery, late-onset complications such as endoleaks have become major issues, requiring lifelong follow-up after EVAR. The clinical guidelines have been updated, and many systematic reviews/meta-analyses and multi-center registries have been published; surgeons must keep up-to-date regarding these changes. In this review, the author reviews evidence on the recent update of the type 2 endoleak management.
腔内血管修复术(EVAR)已在临床上应用了近三十年,随着设备和技术的不断发展,它已在临床实践中得到广泛应用,并已应用于疑难病例。尽管EVAR的主要优势是围手术期死亡率较低,但与开放手术相比,诸如内漏等迟发性并发症已成为主要问题,EVAR术后需要终身随访。临床指南已经更新,许多系统评价/荟萃分析和多中心登记研究也已发表;外科医生必须跟上这些变化。在本综述中,作者回顾了关于2型内漏处理最新进展的证据。